Research activities are mainly focused on genetics of ALS, stem cell therapeutics, and functional studies on pathogenetic mechanisms of disease. The ALS Centre is also involved in clinical research aiming at biomarker identication (neuroradiological, neurophysiological, and CSF) and clinical trials.
Vincenzo SilaniProfessor of Neurology
Vincenzo Silani is Professor of Neurology in the University of Milan Medical School. He is Director of the Department of Neurology-Stroke Unit and the Laboratory of Neuroscience at the IRCCS Istituto Auxologico Italiano.
TUDCA (tauroursodeoxycholic acid) is a small molecule that is being explored for its potential as a treatment for ALSRead more
PreLude (Lithium carbonate)
Within an innovative platform design study, we will evaluate the efficacy of lithium carbonate in UNC13a homozygous patients.Read more
Within an innovative platform design study, we will evaluate the efficacy of Triumeq, a therapy developed for treatment of HIV that has shown to slow progression in ALSRead more
iAdore (Oral edaravone)
Within an innovative platform design study, we will evaluate the efficacy of oral edaravone (TW001), a formulation that reduces oxidative stressRead more